Artelo Biosciences (ARTL) Short Interest Ratio & Short Volume → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free ARTL Stock Alerts $1.32 -0.01 (-0.75%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Artelo Biosciences Short Interest DataCurrent Short Volume4,900 sharesPrevious Short Volume6,100 sharesChange Vs. Previous Month-19.67%Dollar Volume Sold Short$6,739.95Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares3,228,000 sharesFloat Size3,200,000 sharesShort Percent of Float0.15%Today's Trading Volume8,134 sharesAverage Trading Volume15,017 sharesToday's Volume Vs. Average54% Short Selling Artelo Biosciences ? Sign up to receive the latest short interest report for Artelo Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatARTL Short Interest Over TimeARTL Days to Cover Over TimeARTL Percentage of Float Shorted Over Time Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic Artelo Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,900 shares $6,739.95 -19.7%0.2%0.3 $1.38 4/15/20246,100 shares $9,028.00 -57.9%0.2%0.4 $1.48 3/31/202414,500 shares $21,460.00 -28.2%0.5%0.9 $1.48 3/15/202420,200 shares $29,088.00 +9.2%0.6%1.1 $1.44 2/29/202418,500 shares $28,305.00 +117.7%0.6%1.1 $1.53 2/15/20248,500 shares $14,705.00 -38.9%0.3%0.5 $1.73 Get the Latest News and Ratings for ARTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202413,900 shares $19,460.00 -3.5%0.4%0.8 $1.40 1/15/202414,400 shares $21,024.00 -0.7%0.5%0.7 $1.46 12/31/202314,500 shares $20,300.00 -44.9%0.5%0.5 $1.40 12/15/202326,300 shares $35,505.00 -18.1%0.8%0.9 $1.35 11/30/202332,100 shares $45,582.00 +9.9%1.0%0.9 $1.42 11/15/202329,200 shares $37,668.00 +3.6%0.9%0.1 $1.29 10/31/202328,200 shares $34,827.00 -56.4%1.0%0.1 $1.24 10/15/202364,700 shares $92,521.00 +34.8%2.3%0.2 $1.43 9/30/202348,000 shares $70,080.00 -42.7%1.7%0.2 $1.46 9/15/202383,800 shares $128,214.00 +357.9%2.9%0.3 $1.53 8/31/202318,300 shares $34,404.00 +8.9%0.6%0.1 $1.88 8/15/202316,800 shares $33,768.00 -21.9%0.6%1.3 $2.01 7/31/202321,500 shares $41,065.00 -16.7%0.8%1.7 $1.91 7/15/202325,800 shares $51,084.00 -21.8%0.9%1.4 $1.98 6/30/202333,000 shares $66,330.00 +4.4%1.2%1.8 $2.01 6/15/202331,600 shares $64,464.00 +10.5%1.1%1.5 $2.04 5/31/202328,600 shares $51,079.60 +6.7%1.0%1.4 $1.79 5/15/202326,800 shares $45,828.00 +48.9%1.0%1.3 $1.71 4/30/202318,000 shares $29,340.00 -77.3%0.6%0.8 $1.63 4/15/202379,300 shares $206,608.22 +16.3%2.8%4.2 $2.61 3/31/202368,200 shares $158,224.00 +75.3%2.4%3.3 $2.32 3/15/202338,900 shares $89,470.00 -30.3%1.4%1.8 $2.30 2/28/202355,800 shares $159,867.00 -26.0%2.0%2.5 $2.87 2/15/202375,400 shares $226,954.00 +40.2%2.7%3.3 $3.01 1/31/202353,800 shares $173,236.00 -34.5%1.9%2.2 $3.22 1/15/202382,100 shares $267,646.00 -22.9%2.9%3.5 $3.26 12/30/2022106,500 shares $307,785.00 -16.2%3.7%4.8 $2.89 12/15/2022127,100 shares $374,945.00 +37.0%4.5%6.2 $2.95 11/30/202292,800 shares $228,288.00 +4.3%3.3%3.6 $2.46 11/15/202289,000 shares $258,990.00 +11.1%3.1%2.3 $2.91 10/31/202280,100 shares $229,887.00 +11.3%2.8%0.2 $2.87 10/15/202272,000 shares $228,240.00 -4.9%2.5%0.2 $3.17 9/30/202275,700 shares $261,165.00 +30.1%2.7%0.2 $3.45 9/15/202258,200 shares $240,948.00 +39.6%2.1%0.2 $4.14Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company ARTL Short Interest - Frequently Asked Questions What is Artelo Biosciences' current short interest? Short interest is the volume of Artelo Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 4,900 shares of ARTL short. 0.15% of Artelo Biosciences' shares are currently sold short. Learn More on Artelo Biosciences' current short interest. What is a good short interest percentage for Artelo Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.15% of Artelo Biosciences' floating shares are currently sold short. Is Artelo Biosciences' short interest increasing or decreasing? Artelo Biosciences saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 4,900 shares, a decline of 19.7% from the previous total of 6,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Artelo Biosciences' float size? Artelo Biosciences currently has issued a total of 3,228,000 shares. Some of Artelo Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Artelo Biosciences currently has a public float of 3,200,000 shares. How does Artelo Biosciences' short interest compare to its competitors? 0.15% of Artelo Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Artelo Biosciences: TransCode Therapeutics, Inc. (2.29%), TFF Pharmaceuticals, Inc. (4.07%), GT Biopharma, Inc. (0.48%), Clever Leaves Holdings Inc. (2.03%), Tharimmune, Inc. (1.03%), Bright Minds Biosciences Inc. (2.57%), Exicure, Inc. (1.75%), Alzamend Neuro, Inc. (0.47%), Cyclacel Pharmaceuticals, Inc. (29.26%), NexImmune, Inc. (0.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Artelo Biosciences stock? Short selling ARTL is an investing strategy that aims to generate trading profit from Artelo Biosciences as its price is falling. ARTL shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Artelo Biosciences? A short squeeze for Artelo Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARTL, which in turn drives the price of the stock up even further. How often is Artelo Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARTL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: RNAZ Short Interest Data TFFP Short Interest Data GTBP Short Interest Data CLVR Short Interest Data THAR Short Interest Data DRUG Short Interest Data XCUR Short Interest Data ALZN Short Interest Data CYCC Short Interest Data NEXI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARTL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts